Pharma Aids (DHA:PHARMAID) Cyclically Adjusted Book per Share: BDT102.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:PHARMAID Pharma Aids Ltd DHA:PHARMAID
73 GF Score
Price BDT644.70
GF Value BDT758.56
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pharma Aids Cyclically Adjusted Book per Share?

Pharma Aids DHA:PHARMAID -2.55% 73 Cyclically Adjusted Book per Share is BDT102.74 as of Mar. 2026. GuruFocus rates DHA:PHARMAID with a GF Score™ of 73/100 and a GF Value™ of BDT758.56 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pharma Aids's adjusted book value per share for the three months ended in Mar. 2026 was BDT155.554. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is BDT102.74 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pharma Aids's average Cyclically Adjusted Book Growth Rate was 13.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pharma Aids was 10.90% per year. The lowest was 10.90% per year. And the median was 10.90% per year.

As of today (2026-07-17), Pharma Aids's current stock price is BDT644.70. Pharma Aids's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was BDT102.74. Pharma Aids's Cyclically Adjusted PB Ratio of today is 6.28.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Aids was 13.65. The lowest was 4.85. And the median was 8.13.


Pharma Aids  (DHA:PHARMAID) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pharma Aids's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=644.70/102.74
=6.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pharma Aids was 13.65. The lowest was 4.85. And the median was 8.13.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pharma Aids Cyclically Adjusted Book per Share Related Terms


Pharma Aids Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Pharma Aids's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Aids Cyclically Adjusted Book per Share Chart

Pharma Aids Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 68.37 76.05 82.86 93.26

Pharma Aids Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.28 93.26 96.21 98.39 102.74

DHA:PHARMAID vs ISRG, BDX, MDLN: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Pharma Aids's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Aids Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Aids's Cyclically Adjusted PB Ratio falls into.


DHA:PHARMAID
73GF Score
Pharma Aids Ltd DHA:PHARMAID
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Aids Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharma Aids's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=155.554/330.2130*330.2130
=155.554

Current CPI (Mar. 2026) = 330.2130.

Pharma Aids Quarterly Data

Book Value per Share CPI Adj_Book
201606 43.242 241.018 59.245
201609 44.453 241.428 60.801
201612 44.354 241.432 60.664
201703 46.624 243.801 63.149
201706 49.529 244.955 66.768
201709 52.724 246.819 70.538
201712 43.480 246.524 58.240
201803 58.140 249.554 76.932
201806 60.810 251.989 79.687
201809 65.402 252.439 85.552
201812 65.019 251.233 85.459
201903 69.105 254.202 89.769
201906 71.082 256.143 91.637
201909 75.660 256.759 97.305
201912 75.717 256.974 97.297
202003 80.144 258.115 102.530
202006 82.550 257.797 105.739
202009 86.469 260.280 109.702
202012 85.414 260.474 108.283
202103 89.447 264.877 111.510
202106 93.263 271.696 113.350
202109 98.295 274.310 118.327
202112 98.659 278.802 116.852
202203 103.155 287.504 118.479
202206 98.831 296.311 110.139
202209 100.646 296.808 111.973
202212 94.727 296.797 105.392
202303 93.438 301.836 102.223
202306 91.275 305.109 98.785
202309 94.954 307.789 101.872
202312 101.179 306.746 108.920
202403 108.642 312.332 114.862
202406 109.886 314.175 115.495
202409 115.523 315.301 120.987
202412 129.501 315.605 135.495
202503 133.926 319.799 138.287
202506 138.577 322.561 141.864
202509 145.322 324.800 147.744
202512 149.541 324.054 152.383
202603 155.554 330.213 155.554

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of BDT102.74 mean?
Pharma Aids (DHA:PHARMAID) has a Cyclically Adjusted Book per Share of BDT102.74 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pharma Aids and its competitors.
Is Pharma Aids' Cyclically Adjusted Book per Share too high?
Pharma Aids' current Cyclically Adjusted Book per Share is BDT102.74. Overall, Pharma Aids has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Aids' Cyclically Adjusted Book per Share compare to ISRG and BDX?
Pharma Aids' Cyclically Adjusted Book per Share of BDT102.74 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pharma Aids and its competitors. Pharma Aids's current Cyclically Adjusted Book per Share is BDT102.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Aids stock overvalued right now?
Based on GuruFocus' analysis, Pharma Aids (DHA:PHARMAID) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT758.56, compared to a current price of BDT644.70 — trading 15% below its estimated fair value. The current Cyclically Adjusted Book per Share is BDT102.74. Pharma Aids' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Pharma Aids (DHA:PHARMAID), the current Cyclically Adjusted Book per Share is BDT102.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Aids (DHA:PHARMAID) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Aids stock appears to be undervalued. The current stock price of BDT644.70 is trading 15% below its estimated GF Value™ of BDT758.56. GuruFocus considers Pharma Aids to be Modestly Undervalued.

Key valuation signals for DHA:PHARMAID:

  • Cyclically Adjusted Book per Share: BDT102.74
  • GF Value™: BDT758.56 vs. price of BDT644.70 (15% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the DHA:PHARMAID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Aids Business Description

Address 345 Segun Bagicha, 1st Floor, Ramna, Dhaka, BGD, 1000
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
73GF Score

Get the complete analysis for DHA:PHARMAID

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT644.70
Price
BDT758.56
GF Value